Moreno-García, E., Rico, V., Albiach, L., Agüero, D., Ambrosioni, J., Bodro, M., . . . Soriano, A. (2021). Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection. Rev Esp Quimioter.
シカゴスタイル引用形Moreno-García, Estela, et al. "Tocilizumab Reduces the Risk of ICU Admission and Mortality in Patients With SARS-CoV-2 Infection." Rev Esp Quimioter 2021.
MLA引用形式Moreno-García, Estela, et al. "Tocilizumab Reduces the Risk of ICU Admission and Mortality in Patients With SARS-CoV-2 Infection." Rev Esp Quimioter 2021.
警告: この引用は必ずしも正確ではありません.